摘要
根据2019冠状病毒病(COVID-19)患者临床症状,结合《黄帝内经》五运六气理论分析,认为本病属于中医“伏燥寒湿疫”。在确立寒湿致病的同时,应高度关注伏燥致疫,燥邪为伏气、寒湿为时气,伏气与时气交互产生疫毒,导致了COVID-19患者内燥外寒(湿)的病机证候特征。在前期临床实践基础上将本病分为“伏邪内伤,燥热灼肺型”、“寒湿困脾,壅阻肺气型”、“余邪未尽,肺脾两虚型”,分别予葳蕤汤、升阳益胃汤、神术散合生脉散等加减运用。此外,龙砂开阖六气针法非药物疗法在缓解临床症状中有一定疗效,值得关注。
According to the clinical symptoms of Corona Virus Disease 2019(COVID-19)and the theory of the five evolutive phases and six climatic factors in the book of Huangdi Neijing,it is considered that this disease belongs to‘fu-zao-hanshi epidemic disease’.While establishing the pathogenesis of cold-dampness,we should pay close attention to the pathogenesis of Fuzao,the pathogenic dryness is Fuqi,the pathogenic cold-dampness is Shiqi,and the interaction between Fuqi and Shiqi produces epidemic virus,which leads to the pathogenesis and syndrome characteristics of internal dryness and external cold(damp)in COVID-19.On the basis of early clinical practice,the disease was divided into‘latent internal injury,dryness and heat burning lung type’,‘cold-dampness obstructing spleen,obstruction of lung-qi type’,‘remaining pathogenic factors not exhausted,lung and spleen deficiency type’,additional and reduced application of Weirui Decoction,Shengyang Yiwei Decoction,Shenshu Powder combined with Shengmai Powder.In addition,Longsha kai-he six climatic factors acupuncture method acupuncture non-drug therapy in the relief of clinical symptoms have a certain effect,it is worthy of attention.
作者
陆曙
顾植山
陶国水
付德才
高杰元
高广飞
李燚光
王凯军
LU Shu;GU Zhi-shan;TAO Guo-shui;FU De-cai;GAO Jie-yuan;GAO Guang-fei;LI Yi-guang;WANG Kai-jun(Nanjing University of Chinese Medicine Wuxi Affiliated Hospital,Wuxi 214071,China;Wuxi Longsha Institute of Medical Schools,Wuxi 214071,China;Wuxi Infectious Disease Hospital,Wuxi 214007,China;Hanchuan Hospital,Wuhan University People’s Hospital,Hanchuan 431699,China;Baoji Hospital of Traditional Chinese Medicine,Baoji 721000,China)
出处
《中华中医药杂志》
CAS
CSCD
北大核心
2020年第3期1100-1103,共4页
China Journal of Traditional Chinese Medicine and Pharmacy
基金
无锡市卫生计生委重大项目(No.Z201815)
2019年无锡市“太湖人才计划”国际国内顶尖医学团队项目(No.锡组通[2019]68号)
第六批全国老中医药专家学术经验继承工作项目(No.国中医药人教发[2017]29号)。